Clinical Trial Update: Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Blinatumomab with either combination chemotherapy or Dasatinib, Prednisone, and Blinatumomab in older patients with acute lymphoblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia
• Bcr-abl1-positive B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Chemotherapy (combination chemotherapy)
• DASATINIB (Dasatinib)
• PREDNISONE (Prednisone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-01-25